PLUS1
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Corvus Pharmaceuticals Inc | CRVS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.25 | -5.81% | 4.05 | 4.89 | 4.05 | 4.58 | 4.30 | 17:59:44 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 3.75 | 4.43 | 0.68 | 15.35% | 1 | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,283 | 244,193 | $ 4.46 | $ 1,090,133 | 175,934 | 2.53 - 8.10 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:59:39 | 6,794 | $ 4.05 | USD |
Corvus Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 125.00M | 30.86M | $ -46.94M | -1.75 | - | 30.60M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 2.00 | 0.90% |
Corvus Pharmaceuticals News
| Date | Time | Source | News Article |
|---|---|---|---|
| 12/09/2019 | 06:30 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 12/07/2019 | 09:00 | GlobeNewswire Inc. | Corvus Pharmaceuticals Presents Preclinical and Initial.. |
| 11/14/2019 | 16:16 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 11/12/2019 | 09:01 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 11/08/2019 | 16:03 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 11/08/2019 | 07:00 | GlobeNewswire Inc. | Corvus Pharmaceuticals Presents Updated Data from CPI-006.. |
| 11/07/2019 | 08:30 | GlobeNewswire Inc. | Corvus Pharmaceuticals to Present Preclinical and Early.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRVS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.12 | 4.89 | 2.96 | 4.13 | 337,131 | 0.93 | 29.81% |
| 1 Month | 3.42 | 4.89 | 2.62 | 3.44 | 190,079 | 0.63 | 18.42% |
| 3 Months | 3.57 | 4.89 | 2.53 | 3.37 | 136,434 | 0.48 | 13.45% |
| 6 Months | 3.50 | 8.10 | 2.53 | 4.23 | 176,502 | 0.55 | 15.71% |
| 1 Year | 5.86 | 8.10 | 2.53 | 4.20 | 136,274 | -1.81 | -30.89% |
| 3 Years | 15.6166 | 22.1366 | 2.53 | 8.10 | 109,763 | -11.57 | -74.07% |
| 5 Years | 15.00 | 22.1366 | 2.53 | 8.68 | 97,812 | -10.95 | -73.0% |
Corvus Pharmaceuticals Description
| Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on developing and commercializing small molecule and antibody agents that target the immune system to treat patients with cancer. |
